Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)

Slides:



Advertisements
Similar presentations
High Resolution Italian studies Pamela Minicozzi Descriptive Studies and Health Planning Unit, Department of Preventive and Predictive Medicine, Fondazione.
Advertisements

NYCRIS: Rule to Identify Potential Duplicate Tumours (1) Select Patient Cohort Patient Id: Range Date Last Changed: Range Sex: M or F Check Patient Eligibility.
NCRS – TUMOUR MATCHING WORKSHOP 20 th February 2003 – Novotel, Sheffield The SWCIS Method Presented By Tina Ball & Gill Christmas.
1 TCR TUMOUR MATCHING ALGORITHM The structure of the algorithm- Heather Bourne Using the algorithm - Jason Hiscox.
Instructions and Reporting Requirements Module 2 Electronic Reporting For Facilities March 2014 North Carolina Central Cancer Registry State Center for.
Northern & Yorkshire Cancer Registry & Information Service NHS UKACR Conference 30 September How useful is the Cancer Waiting Times (CWT) dataset.
Nadya Dimitrova Marieta Petkova. 13 Regional cancer registries BNCR: -Established in 1952; cases a year; million population;
1 Renal Pelvis, Ureter, Bladder and Other Urinary.
Which women are having a Hysterectomy and why? A plain English presentation of the methodology and findings of a database linkage study Dr Helen Stokes-Lampard.
West Midlands Cancer Intelligence Unit Extending Quality Assurance to all Breast Cancers: the BCCOM Project UKACR Annual Conference 29 September 2004 Gill.
Cancer Registry Coding Changes for 2014 Presented by the Kentucky Cancer Registry February, 2014.
National Cancer Registry Luxembourg EUROCHIP-3 Meeting Ispra, 27 th February 2012 Olivier Collignon, PhD, Sophie Couffignal, MD, CRP-Santé.
Evaluation of Electronic Radiotherapy Data for Quality Checking Cancer Registry Data Colin Fox (NICR) Richard Middleton (NICR) Denise Lynd (BCH – COIS)
Procedures used by CHTN
1 Colon MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Automated Cancer Registration N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)
Cancer registries and rare cancers: quality of data, supplementary information RARECARE WP6 3rd meeting National Institute of Public Health Warsaw 25th.
1 LUNG. 2 Equivalent Terms, Def, Charts, Tables, Illustrations.
Difficulties for the analysis of rare cancers Missing cases Example: angiosarcoma of liver Including false cases Example: malignant digestive endocrine.
1 MP/H Coding Rules General Instructions MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
2010 Hematopoietic and Lymphoid Neoplasm Project Registry Operations and the SEER Program.
Casefinding & Follow-Up Dolores E. McCord, RHIT, CTR Piedmont Hospital Atlanta, Georgia.
Principles of Surgical Oncology Salah R. Elfaqih.
National Oesophago-Gastric Cancer Audit Clinical Audit Platform How to Register, Submit and View Reports CAP: |
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
CANCER INCIDENCE IN NEW JERSEY BY COUNTY, for the Comprehensive Cancer Control Plan County Needs Assessments August 2003 Prepared by: Cancer.
CASEFINDING Debra W. Christie, MBA, RHIA, CTR, CCRP Director, Cancer Research & Data Center University of Mississippi Medical Center.
AUTOMATION IN PRACTISE: The SWCIS Experience Presentated By: Tina Ball …………Head Of Registration Gill Christmas ……Head Of IT 4th December 2002.
Examples of Automation in Practice Trent Cancer Registry Alan Waterhouse Assistant Director (IM&T) Coventry - 4th December 2002 Trent Cancer Registry.
An Outline of Automated Cancer Registration Chris Carrigan National Coordinator for Cancer Registration in England For the Automated Cancer Registration.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
New Data Items MP/H Task Force Multiple Primary Rules Histology Coding Rules 2007.
Oncologic Pathology in Biomedical Terminologies Challenges for Data Integration Olivier Bodenreider National Library of Medicine Bethesda, Maryland -
Vicki LaRue, CTR KCR Abstractor’s Training February 12,
*Be brief, yet thorough enough to allow recoding of the data fields from the text only! * Use accepted abbreviations from Abstractor’s Manual Appendix.
FRENCH high-resolution studies - Breast cancer: 1990, 1997, 2003, 2010 ? - Colorectal cancer: 1990, 1995, 2000, 2005, 2010 ? - Prostate cancer: 1995,
Praque. ESRI/NICO CHAPTER XVIII SYMPTOMS, SIGNS AND ABNORMAL CLINICAL AND LABORATORY FINDINGS, NOT ELSEWHERE CLASSIFIED (R00 –R99) Rashes ‘n’ Things 5.
The management of low-risk basal cell carcinomas in the community Implementing NICE guidance in general practice May 2010 NICE guidance on cancer services.
The Cancer Registry of Norway Jan F Nygård Head of the IT-department.
BY FRANCES ROSS, CTR PRESENTED AT THE NAACCR ANNUAL CONFERENCE JUNE, 2008 Record Consolidation Test with the 2007 Multiple Primary/Histology Rules.
1 Virginia Cancer Registrars Association and Virginia Cancer Registry Annual Meeting October 3, 2007.
RARE SKIN TUMOURS IN THE SOUTH WEST J Weeks, V Poirier, J Verne, C Harling on behalf of the Skin Cancer Tumour Panel Objective NICE Improving Outcomes.
Gary M. Levin, BA, CTR Florida Cancer Data System NAACCR 2008 Annual Conference 2007 Multiple Primary Rules: Impact on Tumor Counts.
1. Multiple Primary and Histology Rules 101 Format of MP/H Materials.
Electronic CAP Cancer Checklists and Cancer Registries – A Pilot Project 2009 NAACCR Conference Ken Gerlach, MPH, CTR Castine Verrill, MS, CTR CDC-National.
RARECARE project Proposal for improving data quality on rare cancers with high priority Granada, March 25 th 2009 Andalusian School of Public Health.
Joy Mennings and Joyce Lomans. Contents Why did we choose this subject? Why is cancer a social issue? What is cancer? Most common kinds of cancer What.
2016 Edits.
Dr Helen Stokes-Lampard
W. Scott Campbell, MBA, PhD James R. Campbell, MD
Skin Cancer Diagnoses and Treatments.
US Mortality, 2003 No. of deaths % of all deaths Rank Cause of Death
Principles of Surgical Oncology
Surgical Cancer Treatment
Automated Consolidation of Collaborative Stage Data Items
Segmented analysis of the lung cancer median pathway from referral to treatment: This work was carried out in partnership between the Transforming.
Prepared by staff in Prevention and Cancer Control.
The 20 Most Common Cancers in 2012
From NICE CG 104, 2010 Table 1 Terms used in this guideline
The 10 Most Common Cancers: 2012
The 10 Most Common Cancers in 2011
NEOPLASM DIAGNOSIS CODING AND SEQUENCING
Prepared by staff in Prevention and Cancer Control.
The 10 Most Common Cancers in 2011
Comparing the multiple sources of cancer treatment data
The Burden of Cancer in Nova Scotia an evaluation of loss in expectation of life Ron Dewar Registry and Analytics Presented to the joint NAACCR.
The Progress of npcr audits What have we done, what have we learned, and where are we going now Click to edit subtitle Click to enter your Division Name.
Text Mining for Data Quality Analysis of Melanoma Tumor Depth
Squamous cell carcinoma pathway update
Presentation transcript:

Tumour Matching N.Ireland Experience Colin Fox (IT Manager) Richard Middleton (Data Manager)

Background to Approach 1 New Registry with a need to produce incidence figures QUICKLY!! System implementation issues - problems with inherent code translations - switch to “Direct Mapping” approach PAS - ICD10 coding from April 1996 Pathology - SNOMED to ICD9/10 translation table Small catchment area, manageable numbers - manual review possible

Background to Approach 2 Bulk of incoming records from PAS and therefore already coded in ICD10 Typical composition of selected tumour sites on NICR system (1998 reg.): Site PAS (max) Path (max) PAS (mean) Path (mean) No. %Hi Lung Breast Skin ~93

Philosophy behind Matching Algorithm Simple - use incoming raw data as much as possible to reduce complexity Repeatable - consistent results Fit for purpose - good enough to provide reasonable accuracy Never be perfect - an understanding of the limitations and any additional countermeasures needed

Tumour Matching Rules 1 NICR match tumours on ICD-10 Receive most data in ICD10 (PAS) Table coverts SNOMED into ICD10 First 3 digits from SOURCE record S are compared to the first 3 digits of tumour registration D(i), where i is the number of tumour registrations for a matched patient Match obtained when S=D(i) Applies to most tumours with some exceptions

Tumour Matching Rules 2 Exceptions Previous Rule applies except for Melanomas (C43), Colon (C18) and Skin (C44) Match based on complete ICD10 code Exception: skins (morphology considered) 1 BCC + 1SCC per patient Same site two tumour morphologies take highest morphology e.g. M80103, M > M81403 on database Exceptions Skins (as above) and Leukaemias & Lymphomas

Tumour Matching Rules 3 Matched tumours are consolidated as follows: If 4th digit in one of S or D(i) is 0-8 and the 4th digit of the other is “9” (NOS) the more specific sub-site is registered e.g. C50.4 & C50.9 –> C50.4 on database If 4th digits in both of S or D(i) differ and are between 0-8 merge as “8” e.g. C15.5 & C15.4 –> C15.8 on database

Updating Date of Diagnosis Preferred date is always “Date of first microscopic verification” – 80% cases in NICR have cytology or pathology If no microscopic verification Manual Resolution (PAS only)“Date of procedure which leads to diagnosis”, we use a Hierarchy e.g. CT better than XR This is different from UKACR & ENCR rules e.g. “Date treatment started” is before “Date of first microscopic verification”

Updating “Basis of Diagnosis” Hierarchy of “Basis of Diagnosis” Histopathology Cytology Clinical Investigation Clinical Opinion Death Certificate Rules same as UKACR & ENCR

Consequences of Approach 1 Loss of Multiple Primaries (currently <6% excluding NM skins) Not the same as UKACR rules ENCR Multiple Primary rules Time does not matter Laterality does not matter Same family of tumour Lose Clinical Statements e.g. “this is a new primary” Cross-checks with “Customers” e.g. Breast Screening

Consequences 2 Inaccurate Coding Pathology report generally “dumb down” text description Centroblastic centrocytic lymphoma gets coded as M95903 NHL “Carcinoma” used fairly freely TCC non invasive pTa coded as M81203 Secondary tumours coded as primary Adenocarcinoma of Liver M81403 should be M81406

Consequences 3 Misleading Information Site pathologist gives is not true site Difference in clinician term and cancer registration Cytology can give misleading information on site and behaviour of tumour Secondary Not very precise site “Sputum” could be lung or elsewhere in respiratory system Malignant cells from non-malignancy “in situ” tumour (Breast) “uncertain” tumour (Bladder)

How do you get round these problems? Make sure computer system can identify them - source history/audit Have access to full written pathology and cytology reports (may need hospital notes) Always check multiple tumours manually Checks on selected sites Compare with other algorithms